Ibandronate in the Treatment of Pediatric Osteoporosis

被引：1
|
作者：
Kutilek, Stepan [1 ,2 ]
Plasilova, Ivana [1 ]
Langer, Jan [3 ]
机构：
[1] Pardubice Hosp, Dept Pediat, Pardubice, Czech Republic
[2] Klatovy Hosp, Dept Pediat, Klatovy, Czech Republic
[3] Charles Univ Prague, Dept Pediat, Med Facil 1, Prague, Czech Republic
来源：
INDIAN PEDIATRICS | 2016年 / 53卷 / 10期
关键词：
Bone mineral density; Fractures; Ibandronate; MONTHLY ORAL IBANDRONATE; CHILDREN;
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
We administered oral ibandronate (once a month) to 7 children (6 boys) with low bone mineral density and prevalent low energy fractures. We observed a significant increase (17%) in bone density after one year and additional 3% increase after second year. No further fractures occurred.
引用
收藏
页码：927 / 927
页数：1
相关论文
共 50 条
  • [21] Ibandronate for prevention and treatment of glucocorticoid-induced osteoporosis in rabbits
    Kun-juan Zhang
    Jian Zhang
    Ze-kun Kang
    Xiao-mei Xue
    Jing-fen Kang
    Yan-wei Li
    Hai-ning Dong
    Dong-gang Liu
    Rheumatology International, 2012, 32 : 3405 - 3411
  • [22] A prospective comparative study of intravenous alendronate and ibandronate for the treatment of osteoporosis
    Horikawa, Akira
    Miyakoshi, Naohisa
    Hongo, Michio
    Kasukawa, Yuji
    Kodama, Hiroyuki
    Shimada, Yoichi
    MEDICINE, 2019, 98 (06)
  • [23] Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis
    Cooper, C
    Emkey, RD
    McDonald, RH
    Hawker, G
    Bianchi, G
    Wilson, K
    Schimmer, RC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10): : 4609 - 4615
  • [24] Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis
    Thiebaud, D
    Burckhardt, P
    Kriegbaum, H
    Huss, H
    Juttmann, JR
    Schoter, KH
    AMERICAN JOURNAL OF MEDICINE, 1997, 103 (04): : 298 - 307
  • [25] Biological properties and mechanism of action of ibandronate: Application to the treatment of osteoporosis
    Epstein, S
    Zaidi, M
    BONE, 2005, 37 (04) : 433 - 440
  • [26] Intravenous ibandronate is an effective and well-tolerated treatment for osteoporosis
    Nature Clinical Practice Rheumatology, 2008, 4 (7): : 335 - 335
  • [27] Four years intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis
    Lamy, O
    Sandini, L
    Burnand, J
    Krieg, MA
    Burckhardt, P
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S188 - S188
  • [28] Ibandronate in the Management of Postmenopausal Osteoporosis
    Reginster, Jean-Yves
    Hiligsmann, Mickael
    Rabenda, Veronique
    Zegels, Brigitte
    Neuprez, Audrey
    Bruyere, Olivier
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1409 - 1421
  • [29] Ibandronate and prevention of postmenopausal osteoporosis
    Maravic, M
    Landais, P
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (05) : 608 - 609
  • [30] Advances in osteoporosis treatment - Once monthly ibandronate for an effective fracture prophylaxis
    不详
    ORTHOPADE, 2007, 36 (02):
12345